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Abstract: Chondroitin sulfate A was covalently immobilized onto a monolithic silica epoxy column
involving a Schiff base formation in the presence of ethylenediamine as a spacer and evaluated in
terms of its selectivity in enantioseparation. The obtained column was utilized as a chiral stationary
phase in enantioseparation of amlodipine and verapamil using a mobile phase consisting of 50 mM
phosphate buffer pH 3.5 and UV detection. Sample dilution by organic solvents (preferably 25% v/v
acetonitrile-aqueous solution) was applied to achieve baseline enantioresolution (Rs > 3.0) of the
individual drug models within 7 min, an excellent linearity (R2 = 0.999) and an interday repeatability
of 1.1% to 1.8% RSD. The performance of the immobilized column for quantification of racemate in
commercial tablets showed a recovery of 86–98% from tablet matrices. Computational modeling by
molecular docking was employed to investigate the feasible complexes between enantiomers and the
chiral selector.
Keywords: amlodipine; chiral stationary phase; chondroitin sulfate A; enantioseparation; immobi-
lization; monolithic column; Schiff base; verapamil
1. Introduction
Polysaccharide-based chiral stationary phases (CSPs) play an important role in enan-
tioseparations of chiral compounds by high-performance liquid chromatography (HPLC) [1].
Due to the asymmetric and long-range helical structures, polysaccharides offer high recog-
nition capacity and enantioselectivity toward broad types of chiral substances [2,3]. As one
of the most prominent separation methods in analysis and preparative purposes, HPLC
using amylose-based and cellulose-based columns delivers excellent performance [4–7].
In the beginning, the utilization of polysaccharide-based CSPs faced a restriction in the
enantioselectivity improvement due to their low compatibility toward polar organic modi-
fiers [8,9]. Therefore, immobilized CSPs are developed to achieve an expansion of column
compatibility with a wide range of solvent polarity [9,10]. Immobilized CSPs typically
could be applied in normal phase (NP)-, reversed-phase (RP)-, and polar-elution mode
with a large diversity of organic solvents as mobile phases [1,11]. On the other hand, coated
CSPs can only be used as a single mode in NP or RP.
Immobilization of a chiral selector onto macroporous silica has been conducted
through a radical copolymerization reaction [12] and a photochemical technique [9]. In
2017, Bezhitashvili et al. reported highly efficient separation using a wide pore silica surface
as the backbone for high molecular weight polysaccharide-based chiral selectors [12,13] by
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providing loading capacity [14]. In line with these achievements, a previous study on the
covalent immobilization of monolithic silica via epoxide moiety has improved separation
efficiency and compatibility with numerous organic solvents [15].
Among polysaccharides, chondroitin sulfates have been found to be potential chiral
selectors in capillary electrophoresis (CE) [16]. As charged molecules, they possess different
mobility under an electrical field compared to neutral polysaccharides. In addition to their
charges, chondroitin sulfates afford ionic and hydrophobic interactions as well as hydrogen
bonds. Therefore, chondroitin sulfate A (CSA) with the sulfate group at carbon number
four (Figure 1) has been successfully utilized as a chiral selector in CE [17]. Since then,
chondroitin sulfate B [18], D, and E [19] have been employed as chiral selectors for various
chiral substances.
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onolithic silica columns show d successful applications as one current approach for
fast HPLC analysis [3,21–23]. A combination of the broad enantiomers recognition ability
of CSA and the benefits of the monolith backbone is interesting for further investigation
of chromatographic enantioseparations. The immobilization of a chiral selector on a
mo olithic chromatographic support through epoxy and Schiff base formations have been
establishe [24–27]. Particularly, its application on monolithic epoxy support in capillary
liquid chromatography (CLC) [28] and HPLC via in situ modification has been successfully
obtained [15,27]. Moreover, in general, immobilization through a Schiff base formation
proves to be the best approach [24]. Based on our best knowledge, the usage of CSA as a
chiral s lector in HPLC either as a mobile ph se additive r CSP has not been reported.
Molecular docking is commonly used in chiral separation studies to clarify the chiral
recognition mechanism [29,30]. A docking approach might be employed to simulate
the interactions between a chiral selector and the individual enantiomers. The most
stable intermolecular conformation could be simulated with regard to the lowest binding
energy [30].
In this study, the immobilization of CSA onto a monolithic column by sequential Schiff
base formation and reduction was developed to provide an alternative polysaccharide-
based CSP for chromatographic enantioseparation. The enantioseparation capability of
the immobilized CSA column was evaluated by using amlodipine (AML) and verapamil
(VER) in their racemic form as chiral analytes. Both compounds are calcium channel
antagonist drugs, belonging to the classes of dihydropyridines and non-dihydropyridines,
respectively. Further evaluation of the column performance in enantioseparation was
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carried out using commercial tablet matrices. Additionally, molecular docking was utilized
to simulate the enantiorecognition and visualize the feasible interaction between CSA and
the individual enantiomers.
2. Results
2.1. Organic Modifier Effects
The polarity of the mobile phase can be tuned by changing the type and concentration
of an organic additive. Consequently, the recognition mechanism can be strongly influ-
enced [31–33]. The organic solvent can be added in the mobile phase or as sample diluent.
In order to enhance the enantioresolution of amlodipine (AML) and verapamil (VER), the
addition of an organic modifier in the sample solvent was applied. The concentrations of
methanol (MeOH) and acetonitrile (MeCN) in aqueous solution as sample solvents were
optimized, while the mobile phase composition was kept constant. The effect of organic
modifier content on enantioseparation was investigated at 10–100% v/v MeOH (in water)
and 10–100% v/v MeCN (in water).
The increases of MeOH concentrations in the sample solvent gradually improved
the resolution (Rs) of AML and VER. However, up to the solvent composition of 100%
v/v MeOH, only partial enantioseparations of AML and VER were reached with Rs = 0.8
and Rs = 1.1, respectively. The appearances of peak plateaus and coalescence indicate
competition between chromatographic resolution and on-column stereoisomerism [34],
known as dynamic interconversion HPLC [35]. The racemization of the analyte during
passing throughout the column drives the rise of the baseline pattern [36]. In some cases,
low-temperature conditions in chromatographic separations were applied to prevent in-
terconversion by conducting a slow exchange system [34,35]. In this study, the addition
of 10% v/v to 25% v/v MeCN (in water) as a sample solvent significantly increased the
response of the first eluted enantiomer and led to complete peak decoalescence. The influ-
ence of organic modifiers as the sample diluent toward enantiomeric separation profiles is
shown in Figure 2.




Figure 2. Influence of methanol (MeOH) and acetonitrile (MeCN) as organic solvents in various 
concentrations of sample diluent towards enantioseparation profiles of (A) amlodipine, AML and 
(B) verapamil, VER, as racemic mixtures. Stationary phase: CSA column; mobile phase: 50 mM 
phosphate buffer pH 3.5; flow rate 0.8 mL/min; UV detection (A) 240 nm and (B) 230 nm. The or-
ganic solvent was prepared in water (aqueous solution). 
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2.2. Resolution and Selectivity
Resolution (Rs) of AML and VER was obtained at Rs = 3.2 and Rs = 3.6, respectively.
Furthermore, the enantioselectivity of α = 1.8 for AML and α = 2.1 for VER, was achieved
as shown in Table 1.
Table 1. Evaluation of CSA column.
Parameter AML VER
t1 (min) 2.2 ± 3.3 × 10−3 2.2 ± 2.0 × 10−3
t2 (min) 3.2 ± 3.7 × 10−2 3.6 ± 0.2
Rs 3.2 ± 8.5 × 10−2 3.6 ± 8.5 × 10−2
k1 1.4 ± 3.0 × 10−3 1.4 ± 3.0 × 10−3
k2 2.5 ± 7.4 × 10−2 2.9 ± 0.2
α 1.8 ± 2.8 × 10−2 2.1 ± 0.1
N1 4532 ± 408 4407 ± 368
N2 1049 ± 92 589 ± 36
t1: first eluted enantiomer; t2: second eluted enantiomer. Separation conditions: mobile phase: 50 mM phosphate
buffer pH 3.5; flow rate 0.8 mL/min; sample solvent: 25% v/v MeCN (in water); injection volume: 20 µL; UV
detections: 240 nm (AML) and 230 nm (VER). N1: number of theoretical plates of first eluted enantiomer; N2:
number of theoretical plates of second eluted enantiomer.
2.3. Method Validation
Proportional responses of the analyte in triplicate injections of five concentrations
have shown decent linearity for both drug models. Intraday and interday repeatabilities of
peak area ratio were obtained at 0.5–1.3% and 1.1–1.8% RSD, respectively. The RSD values
are indicating satisfactory precision of the separation method. Method accuracy by adding
a respective amount of analyte at 50 µg/mL, 80 µg/mL, and 100 µg/mL was achieved at
98–102% and 95–104% for AML and VER, respectively. Validation parameters are shown in
Table 2.
Table 2. Validation of the enantioseparation method using immobilized-CSA column.
Parameter
AML VER
t1 t2 t1 t2
Range (µg/mL) 50–120 50–120 50–200 50–200
Linearity (R2) 0.9995 0.9985 0.9989 0.9988
Regression y = 95.3 × 103 x + 132.6 × 104 y = 102.9 × 103 x − 373.7 × 104 y = 90.5 × 103 x + 147.5 × 104 y = 80.8 × 103 x − 102.3 × 104
LOD a (µg/mL) 2 3 4 6
LOQ b (µg/mL) 6 10 11 17
Intraday precision * 1.0–1.3% 1.0–1.3% 0.5–1.2% 0.5–1.2%
Interday precision ** 1.2–1.8% 1.2–1.8% 1.1–1.2% 1.1–1.2%
Accuracy 99–102% 98–102% 95–102% 98–104%
a based on 3.3 RMSE/slope. b based on 10 RMSE/slope; RMSE: root mean square error. * repeatability of peak area ratio (n: samples = 9;
df : degrees of freedom = 6). ** repeatability of peak area ratio (days: 3). t1: first eluted peak. t2: second eluted peak.
2.4. Enantioseparation in Commercial Tablet Matrices
The modified column also proved its selectivity towards commercial tablets’ matrices
of A (5 mg AML) and B (80 mg VER). Sample pretreatment through solvent addition
(25% v/v MeOH in water) and ultrasonication was taken to release the analyte from its
matrix and followed by filtration. The proposed method was able to determine the active
substance of selected pharmaceutical dosage form in triplicate with an average of 86%
(2.5% RSD, n = 9, df = 6) and 98% (3.0% RSD, n = 9, df = 6) for AML and VER, respectively.
Separation profile of the enantiomers in tablet matrices is given in Figure 3.
Pharmaceuticals 2021, 14, 98 5 of 14
Pharmaceuticals 2021, 14, x FOR PEER REVIEW 5 of 14 
 
 
Table 2. Validation of the enantioseparation method using immobilized-CSA column. 
Parameter AML VER 𝒕𝟏  𝒕𝟐  𝒕𝟏  𝒕𝟐  
Range (µg/mL) 50–120 50–120 50–200 50–200 
Linearity (R2) 0.9995 0.9985 0.9989 0.9988 
Regression y = 95.3 × 103 x + 132.6 × 104 y = 102.9×103 x − 373.7 × 104 y = 90.5 × 103 x + 147.5 × 104 
y = 80.8 × 103 x 
− 102.3 × 104 
LOD a (µg/mL) 2 3 4 6 
LOQ b (µg/mL) 6 10 11 17 
Intraday precision * 1.0–1.3% 1.0–1.3% 0.5–1.2% 0.5–1.2% 
Interday precision ** 1.2–1.8% 1.2–1.8% 1.1–1.2%  1.1–1.2% 
Accuracy 99–102% 98–102% 95–102% 98–104% 
a based on 3.3 RMSE/slope. b based on 10 RMSE/slope; RMSE: root mean square error. * repeatability of peak area ratio (n: 
samples = 9; df: degrees of freedom = 6). ** repeatability of peak area ratio (days: 3). t1: first eluted peak. t2: second eluted 
peak. 
2.4. Enantioseparation in Commercial Tablet Matrices 
The modified column also proved its selectivity towards commercial tablets’ matrices 
of A (5 mg AML) and B (80 mg VER). Sample pretreatment through solvent addition (25% 
v/v MeOH in water) and ultrasonication was taken to release the analyte from its matrix 
and followed by filtration. The proposed method was able to determine the active sub-
stance of selected pharmaceutical dosage form in triplicate with an average of 86% (2.5% 
RSD, n = 9, df = 6) and 98% (3.0% RSD, n = 9, df = 6) for AML and VER, respectively. Sepa-
ration profile of the enantiomers in tablet matrices is given in Figure 3. 
 
Figure 3. Determination of active pharmaceutical ingredients in commercial tablet matrices. The 
chromatograms represent amlodipine (AML) 80 µg/mL and verapamil (VER) 100 µg/mL with 
their individual reference standards at the corresponding concentrations. 
2.5. Intermolecular Interactions Revealed by Molecular Docking 
As per molecular docking, the interactions between CSA and enantiomers seem to be 
driven by hydrogen bonding. The interactions of CSA towards R-(+)-amlodipine were 
Figure 3. Determination of active pharmaceutical ingr dients in commercial tablet m trices. The chromatograms rep-
resent amlodipine (AML) 80 µg/mL and vera amil (VER) 100 µg/mL with their individual reference standards at the
corresponding concentrations.
2.5. Intermolecular Interactions Revealed by Molecular Docking
As per molecular docking, the interactions between CSA and enantiomers seem to
be driven by hydrogen bonding. The interactions of CSA towards R-(+)-amlodipine were
dominated by hydrogen bonding between (SO···) and (···HN) of the primary amine, among
two electrostatic binding forces. In contrast, other than a conventional hydrogen bond and
an electrostatic interaction, the primary amine of S-(−)-amlodipine possessed electrostatic
π-anion (chlorophenyl ring··· and ···O-S) interaction, which were not found in its antipode.
The different types of interactions, along with the resulted binding affinities, may lead to
the enantioseparation of AML.
In the case of VER, the secondary amine plays an important role in the molecular
interaction. R-(+)-verapamil formed a hydrogen bond from the interaction between the
ionized tertiary amine and (···-O-) group of CSA. On the other hand, S-(−)-verapamil
formed an hydrogen bond from the interaction between the ionized tertiary amine (NH···)
and (···O=S) group of CSA. Two π-sulfur interactions were found in the R-(+)-enantiomer
and only one in the S-(−)-enantiomer. Additionally, an electrostatic interaction was only
present in by S-(−)-verapamil. Thus, the differences in the complexes of VER enantiomers
might occur. The populations in the best clusters from 250 docking runs for each enantiomer
were 44 for R-(+)-amlodipine, 67 for S-(−)-amlodipine, 28 for R-(+)-verapamil, and 19 for
S-(−)-verapamil. The estimated lowest binding energies in the best clusters are listed in
Table 3, which correspond to the complexes and the molecular interactions briefly depicted
in Figure 4.
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Table 3. Proposed interactions by molecular docking and binding energies.
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lization of various ligands, including performing in house generation of CSA-based CSP. 
The strategy of CSA immobilization onto the monolithic epoxy column was initialized by 
opening the epoxy ring through hydrolyzation to a diol. The oxidizing agent NaIO4 was 
utilized to cleave the diol groups to an aldehyde. The formation of aldehydes was in-
tended to provide an active surface for the attachment of diamine-spacer. The primary 
amines of the spacer were expected to bind to aldehydes by forming a Schiff base linkage 
(imine formation) under alkaline conditions. Ethylenediamine, as the selected diamine-
spacer, was introduced into the column in a continuous flow system with a reductant 
(NaCNBH3, 5 mM) under mildly basic conditions ((NH4)2SO4, 1.9 M) at pH 8.0. In the next 
step, NaCNBH3 (20 mM) was utilized at pH 3.0 to drive the immobilization of ethylene-
diamine to completion by quenching the remaining residual aldehydes on the monolithic 
surface. In order to neutralize the immobilized column, a phosphate buffer was employed 
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functional groups in the predicted interactions.
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3. Discussion
3.1. Immobilized CSA Column
A protocol of stepwise immobilization onto monolithic epoxy HPLC column via
reductive amination has been proposed by Merck. This approach is applicable for immobi-
lization of various ligands, including performing in house generation of CSA-based CSP.
The strategy of CSA immobilization onto the monolithic epoxy column was initialized by
opening the epoxy ring through hydrolyzation to a diol. The oxidizing agent NaIO4 was
utilized to cleave the diol groups to an aldehyde. The formation of aldehydes was intended
to provide an active surface for the attachment of diamine-spacer. The primary amines
of the spacer were expected to bind to aldehydes by forming a Schiff base linkage (imine
formation) under alkaline conditions. Ethylenediamine, as the selected diamine-spacer,
was introduced into the column in a continuous flow system with a reductant (NaCNBH3,
5 mM) under mildly basic conditions ((NH4)2SO4, 1.9 M) at pH 8.0. In the next step,
NaCNBH3 (20 mM) was utilized at pH 3.0 to drive the immobilization of ethylenediamine
to completion by quenching the remaining residual aldehydes on the monolithic surface.
In order to neutralize the immobilized column, a phosphate buffer was employed at pH
7.4 (Figure 5A). A solution of 100 mM NaIO4 in 20% v/v MeOH (aqueous solution) was
prepared to conduct the oxidative cleavage of CSA, prior to introducing to the column
(Figure 5B). The immobilization of CSA (Figure 5C) was carried out via Schiff base forma-
tion using reductant NaCNBH3 (5 mM) under a mild basic condition of (NH4)2SO4 (1.9 M)
pH 8.0 in a continuous flow system. A subsequent process of quenching the remaining
aldehydes employing NaCNBH3 (20 mM) at pH 3.0 and column neutralization using
phosphate buffer pH 7.4 led to the completion of CSA immobilization.
In this protocol, the primary amine as a spacer was expected to bind to aldehydes
via Schiff base linkage. However, the Schiff base linkage is susceptible to hydrolysis and
can revert to the aldehyde and primary amine. Thus, the linkage needs to be stabilized by
reduction to a secondary amine bond. Therefore, the reaction was conducted using reduc-
tant NaCNBH3 (5 mM) to perform an in situ reductive amination reaction. The reaction
between diamine groups and aldehydes might also give side products such as imidazolines,
formed as aminal from the diamine, or diimines from reactions of neighboring aldehydes
of the stationary phase [37]. Nevertheless, the immobilization process of ethylenediamine
in this scheme was focused on the formation of imines as the main product.
In order to conduct applicability and simplicity, the immobilization was performed on
a monolithic analytical column. The immobilization was carried out in a closed continuous
flow system to carry out a constant and stable process. In the applied protocol, an in-
process determination of yields and column characterization was not possible. Therefore,
subsequent rinsing was employed using NaIO4 at an alkaline pH as a control strategy
to minimize unwanted side products and stabilize the intended reaction. However, the
presence of NaIO4 in the overnight immobilization system led to gradual oxidation of the
remaining solution containing CSA. Thus, after the overnight immobilization process, the
determination of the remaining yield less represents the main reaction involved due to grad-
ual oxidation. Likewise, a characterization of the column surface by taking out the monolith
from the column housing and a cross-section cutting was not feasible. Due to these restric-
tions, the immobilized column was evaluated through its performance in enantioseparation.
Investigation of the immobilization process reproducibility becomes a further step that
follows the column evaluation results. This initial report proposed an immobilization
method of CSA onto a monolithic column and its performance in enantioseparation.
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Figure 5. Schematic immobilization of CSA onto the monolithic epoxy column. Introduc i n of diamine-spacer (A),
oxidation of chondroitin sulfate A (CSA) (B), and immobilization of S (C).
3.2. Enantioseparation
The enantiomeric separation was optimized using phosphate buffer, considering
the final solution for the column washing. An acidic pH at 3.5 was applied to achieve
fully ionized basic drugs. Hence, the sulfate group of CSA as an anionic chiral selector
was predicted to be the most important for enantiorecognition by providing electrostatic
interactions with the cationic analyte [38]. Apparently, the addition of organic solvent in
the mobile phase progressively decreased the retention time and resulted in poor resolution
(data not shown). This typical separation behavior is known in an RP system [32]. However,
the presence of an organic solvent in a small amount was found to be required to achieve
baseline resolution. Therefore, the mobile phase of 50 mM phosphate buffer pH 3.5 was
selected for further study with a small volume addition of organic modifier in the sample
solvent. Interestingly, the resolution of the enantiomers was remarkably improved in
the presence of MeCN (25% v/v in water). It might correspond to the higher polarity
of MeCN, which elevates enantioselectivity with less competition in hydrogen-bonding
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interaction compared to MeOH [39]. The immobilized CSA column performed initial
enantioseparation on RP mode HPLC. Thus, expansion of the CSA column applicability in
NP mode separation remains an interesting aspect of future research.
3.3. Molecular Docking and Chromatographic Enantioseparation
HPLC analysis is known to have a limitation in providing direct evidence of the
specific binding sites of analytes with the chiral selector. On the other hand, computational
docking offers further insights into the detailed geometry information and binding energy
of the chiral selector-analyte complex [40]. Thus, computational docking has been proposed
as simple approaches for understanding the chiral recognition mechanism on CSPs [41–44].
A comprehensive docking study on the factors affecting enantioseparation such as solvent
effect and other achiral influence was appointed as quantitative approach along with more
complex interaction model. However, a molecular docking study was often performed in a
vacuum without considering the effect of the medium in the actual separation condition.
Consequently, a difference in the predicted energy by molecular modeling and the result
from the HPLC analysis might occur. Despite that fact, docking approach delivers a
close qualitative estimation regarding the nature of intermolecular forces responsible for
the complexes. Although molecular docking does not account for the actual separation
conditions, strong correlations of binding affinity scores with chromatography elution
orders have been reported [45,46]. In order to assess feasible molecular interactions between
the immobilized CSA stationary phase and the analyte, a basic docking approach using
AutoDock 4.2.6 was applied.
In this study, the molecular docking was simulated on the three-dimensional structure
of CSA and the individual enantiomers at acidic pH. The molecules of CSA and enantiomers
were set up as a rigid selector and flexible ligands, respectively. The most stable complexes
result in binding energies (∆G) that do not take solvation effects into account. Even
though these limitations might lead to the differences between the calculated binding
energies and experimental results [29], the applied method offers preliminary insights into
enantiomer-specific interactions of the study-related structures [45]. Herein, the sulfate
group of CSA was found to play an important role in the chiral recognition of both drug
models. It showed a close agreement with the previous study by Nishi et al. using capillary
electrophoresis [17]. The difference in binding forces and the ∆G values between two
enantiomers might define their separation on CSA column chromatography. Based on the
predicted binding energies, R-(+)-amlodipine and R-(+)-verapamil might have retained
longer in the column than their counterparts.
4. Materials and Methods
4.1. Chemicals and Reagents
Methanol and acetonitrile (gradient grade for liquid chromatography) were obtained
from Merck (Darmstadt, Germany). Sulfuric acid (H2SO4) 96%, ortho-phosphoric acid
(H3PO4, 85%), sodium periodate (NaIO4), sodium cyanoborohydride (NaCNBH3), ethylene-
diamine (NH2CH2CH2NH2), disodium hydrogen phosphate (Na2HPO4), chondroitin
sulfate A sodium salt from bovine trachea, (R,S)-amlodipine as amlodipine besylate,
and (R,S)-verapamil (pharmaceutical secondary standard) were acquired from Sigma-
Aldrich Chemie GmbH (Steinheim, Germany). Water was purified by Arium® pro UF/VF-
Sartophore 0.22 µm water purification system from Sartorius Weighing Technology GmbH
(Göttingen, Germany).
4.2. Instrumentation and Chromatographic Conditions
HPLC analysis was conducted using a VWRTM-Hitachi (VWR International GmbH,
Darmstadt, Germany) consisting of an L-2455 DAD detector, an L-2130 pump, and an L-
2200 autosampler. System management and data acquisition were performed by EZChrom
Elite® 3.3.2 SP2 Software (VWR International GmBH, Darmstadt, Germany) involving inte-
gration parameters of peak area, retention time, and resolution. A Chromolith® Widepore
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300 Epoxy 100-4.6 mm HPLC column was kindly provided by Merck KGaA, Germany.
Enantiomer separations were performed at ambient column temperature and flow rate
of 0.8 mL/min with a mobile phase 50 mM Na2HPO4 pH 3.5 (adjusted by addition of
about 4 mL H3PO4 85% in 1 L buffer solution). An injection volume of 20 µL was set up at
detection wavelengths of 230 nm and 240 nm.
4.3. Preparation of the Immobilized CSP
4.3.1. Conversion of Epoxy Groups and Immobilization of Diamine Spacer
An immobilization approach was applied to develop a CSA-based CSP via a Schiff
base formation. A Chromolith® Widepore 300 Epoxy 100-4.6 mm monolithic HPLC column
was used as a backbone of the immobilized CSA. Epoxy groups of the monolithic column
were first converted to diol groups by hydrolyzation. This step was applied at a flow rate
of 0.2 mL/min using 2% v/v H2SO4 in water for 24 h. In order to cleave the diol groups to
an aldehyde, the process was continued by rinsing the column with 100 mM NaIO4 in 20%
v/v MeOH (aqueous solution) at a flow rate of 0.2 mL/min for 15 h. At the following step,
83 mM ethylenediamine in 50 mM Na2HPO4 containing a mixture of 1.9 M (NH4)2SO4 pH
8.0 and 5 mM NaCNBH3 was introduced into the column at a flow rate of 0.2 mL/min
for 20 h. The immobilization of diamine-spacer was ended by flushing the column with
20 mM NaCNBH3 in 50 mM Na2HPO4 pH 3.0 at a flow rate of 0.2 mL/min for 8 h, and
neutralizing with 100 mM Na2HPO4 pH 7.4 at a flow rate 0.2 mL/min for 5 h. All of the
employed solutions in this step were prepared in water as solvent.
4.3.2. Oxidation of CSA
The oxidation of 1% w/v CSA was applied by converting the hydroxy groups to the
aldehyde groups using 100 mM NaIO4 in 20% v/v MeOH (aqueous solution).
4.3.3. Immobilization of CSA
The immobilization via Schiff base formation was conducted by introducing a mixture
of the oxidized CSA (1% w/v) and 5 mM NaCNBH3 as a reductant containing 1.9 M
(NH4)2SO4 pH 8.0 in 50 mM Na2HPO4, at a constant low flow rate of 0.1 mL/min for
20 h. In the following step, solution of 20 mM NaCNBH3 in 50 mM Na2HPO4 pH 3.0 was
employed at a flow rate of 0.2 mL/min for 8 h. As the last step, the column was flushed
using 50 mM Na2HPO4 pH 7.4 at 0.2 mL/min for 5 h.
4.4. Preparation of Bulk Samples
Stock solutions of AML and VER were prepared individually at the concentration of
1.0 mg/mL in 5% v/v MeOH (aqueous solution). The samples were freshly prepared by
diluting each stock solution into 30 µg/mL in various ratios of MeOH as well as acetonitrile
(MeCN) as solvent.
4.5. Method Validation
Validation of enantioseparation method on the immobilized CSA-based column was
performed in the range concentration of AML (50–120 µg/mL) and VER (50–200 µg/mL) at
a wavelength of 240 nm and 230 nm, respectively. Phosphate buffer 50 mM at acidic pH 3.5
was chosen at a flow rate 0.8 mL/min. Limit of detection (LOD) and limit of quantitation
(LOQ) were calculated as 3.3 times and 10 times the root mean square error (RMSE) divided
by the slope of the calibration curve, respectively. Intraday and interday precision of the
peak area ratio were determined at three concentrations within 50–100 µg/mL.
4.6. Determination of Enantiomers in Commercial Tablets
A further step was taken in order to perform enantioseparation on the immobilized
column using commercial tablet matrices of AML (5 mg amlodipine besylate) and VER
(80 mg verapamil HCl). Series concentrations of grounded AML and VER tablets were
treated individually and dissolved in 5% v/v MeOH (aqueous solution) by ultrasonication
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for 5 min at room temperature. Finally, the samples were filtered through a 0.22 µm filter
membrane to obtain a clear solution and diluted in 25% v/v MeCN (aqueous solution) to
final concentrations of 60–100 µg/mL of the active substance. Three samples were prepared
for each drug and injected in triplicate.
4.7. Data Evaluation
Resolution (Rs) between two enantiomers was determined by the mid-height of
the peaks, where t1 and t2 represent the retention times of the first and second eluted
peaks, respectively, while w1 and w2 correspond to widths at the mid-height of the peaks.
Retention factors of k1 and k2 are described as the ratio of ∆t between two enantiomers











In general, as a polysaccharide, CSA exposes many types of chiral binding sites.
However, the determination is challenging [40]. Thus, a computational method using
molecular docking was employed to figure out the feasible complexes. The simulation was
conducted using a 3D conformer of the CSA structure taken from the Protein Data Bank
(PDB) server entry 4N8W (rcsb.org/structure/4N8W) [20]. The selected CSA consisting
of three monomer units was extracted from its crystal structure 4N8W (cathepsin K-
chondroitin sulfate complex). Drug structures of R-(+)-amlodipine CID_9801597, S-(−)-
amlodipine CID_9822750, R-(+)-verapamil CID_65808, S-(−)-verapamil CID_92305 were
selected from Pubchem. The structures of the enantiomers were stabilized through MMFF94
geometry optimization using Avogadro version 1.2.0 software and finalized in mol2 format.
AutoDock 4.2.6 software (The Scripps Research Institute, La Jolla, CA, USA) was employed
to accomplish docking calculations using the Lamarckian Genetic algorithm. In order
to involve the charges of drug-related structures, the Gasteiger–Hückel calculation was
applied. Grid box size of 30 × 30 × 30 Å was set up with a spacing of 0.375 Å. For each
final structure of complexes of 250 independent docking runs was performed. The lowest
binding energies represent the most stable analyte-selector complex. Biovia Discovery
Studio Visualizer v20.1.0.19295, copyright © 2019 (Dassault Systèmes Biovia Corp, Vélizy-
Villacoublay, France) was utilized to visualize the complexes.
5. Conclusions
This preliminary study reports the in house generation of an immobilized CSA-based
CSP and its performance in chromatographic enantioseparation. CSA immobilization
was successfully conducted onto a Chromolith® Widepore 300 Epoxy 100-4.6 mm HPLC
column via a reductive amination strategy involving Schiff base formation in the presence
of a diamine-spacer. The modified column exhibited chiral separation toward AML and
VER in bulk samples and tablet matrices. Molecular docking projected insights into
feasible complexes along with the molecular interaction between CSA and the individual
enantiomers, which were found to be dominated by hydrogen bonding. The difference of
binding energy (∆G) of two enantiomers might correspond to their retention on the CSA-
based chromatography column. A study on the immobilized CSA column applicability in
various HPLC modes remains attractive for future research.
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